| Audrey Caroline Smith, | |
|
1303 N 188th St, Elkhorn, NE 68022-4501 | |
| (402) 637-1333 | |
| Not Available |
| Full Name | Audrey Caroline Smith |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 4 Years |
| Location | 1303 N 188th St, Elkhorn, Nebraska |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477170082 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | PA13686 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercy Hospital Northwest Arkansas | Rogers, AR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mercy Health Northwest Arkansas Communities | 0648177873 | 265 |
News Archive
A panel of experts charged with reviewing all the available evidence on morbid obesity and weight loss surgery today concluded weight loss surgery is the most effective treatment available and can result in the improvement or complete resolution of diseases associated with obesity, according to a consensus statement published in the April edition of the Journal of the American College of Surgeons (JACS).
Ablexis, LLC, a biotechnology company dedicated to developing an innovative, next-generation platform for antibody drug discovery, announced today that it has completed a $12 million Series A financing. The round was led by Third Rock Ventures and included Pfizer Venture Investments. Proceeds from the financing will be used to continue advancing Ablexis' proprietary AlivaMab Mouse transgenic mouse platform for the discovery of human therapeutic antibodies.
Cancer Research UK-funded scientists are to examine whether identifying patterns in medication given to patients before they develop cancer could improve early diagnosis.
US consumers' preference for lighter beverages is impacting alcoholic drinks innovation. The low-calorie and low-sugar labels seen in emerging products such as hard seltzers (also known as alcoholic waters) particularly appeal to US millennials, 66% of which state they are often or always influenced by how a product impacts their health and wellbeing when choosing alcoholic beverages.
Ampio Pharmaceuticals, Inc. (AMPE), a clinical stage biopharmaceutical company, with repurposed drugs and new molecular entities (NMEs) that treat inflammatory diseases, including osteoarthritis, diabetic macular edema (DME) and sexual dysfunction announced today that it has entered into a definitive agreement with Ethypharm Ltd for the manufacturing of Zertane, Ampio's drug for the treatment of premature ejaculation.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Audrey Caroline Smith, 1303 N 188th St, Elkhorn, NE 68022-4501 Ph: (402) 637-1333 | Audrey Caroline Smith, 1303 N 188th St, Elkhorn, NE 68022-4501 Ph: (402) 637-1333 |
News Archive
A panel of experts charged with reviewing all the available evidence on morbid obesity and weight loss surgery today concluded weight loss surgery is the most effective treatment available and can result in the improvement or complete resolution of diseases associated with obesity, according to a consensus statement published in the April edition of the Journal of the American College of Surgeons (JACS).
Ablexis, LLC, a biotechnology company dedicated to developing an innovative, next-generation platform for antibody drug discovery, announced today that it has completed a $12 million Series A financing. The round was led by Third Rock Ventures and included Pfizer Venture Investments. Proceeds from the financing will be used to continue advancing Ablexis' proprietary AlivaMab Mouse transgenic mouse platform for the discovery of human therapeutic antibodies.
Cancer Research UK-funded scientists are to examine whether identifying patterns in medication given to patients before they develop cancer could improve early diagnosis.
US consumers' preference for lighter beverages is impacting alcoholic drinks innovation. The low-calorie and low-sugar labels seen in emerging products such as hard seltzers (also known as alcoholic waters) particularly appeal to US millennials, 66% of which state they are often or always influenced by how a product impacts their health and wellbeing when choosing alcoholic beverages.
Ampio Pharmaceuticals, Inc. (AMPE), a clinical stage biopharmaceutical company, with repurposed drugs and new molecular entities (NMEs) that treat inflammatory diseases, including osteoarthritis, diabetic macular edema (DME) and sexual dysfunction announced today that it has entered into a definitive agreement with Ethypharm Ltd for the manufacturing of Zertane, Ampio's drug for the treatment of premature ejaculation.
› Verified 6 days ago
Mrs. Bonnie Wilkerson, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 717 N 190th Plz, Ste. 1100, Elkhorn, NE 68022 Phone: 402-815-1700 Fax: 402-815-1959 | |
Brittany Ann Reeg, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 3423 N 191st Ave, Elkhorn, NE 68022 Phone: 402-885-7682 | |
Anna Elizabeth Prauner, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 222 N 192nd St, Elkhorn, NE 68022 Phone: 402-390-4111 Fax: 402-390-4115 | |
Brianna R Thacker, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 717 N 190th Plz Ste 3200, Elkhorn, NE 68022 Phone: 402-815-1980 Fax: 402-815-1961 | |
Ronda Jean Foley, Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 20160 Harney St, Elkhorn, NE 68022 Phone: 402-740-0563 | |
Erin Alise Sloup, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 222 N 192nd St, Elkhorn, NE 68022 Phone: 402-390-4111 Fax: 402-390-4115 | |
Joli Hallowell, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 717 N 190th Plz, Ste. 3100, Elkhorn, NE 68022 Phone: 402-815-1325 Fax: 402-815-2020 |